glp 1 blindness study Full article: Glucagon-Like Peptide-1 Analogs Associated with a Reduced Risk of Legal in Type 2 Diabetics with Cardiovascular Risks You've seen the headlines. Should

As of December 2025, GLP-1 RA prescriptions account for more than 7% of all prescriptions

Pasternak B, Wintzell V, Eliasson B, Svensson AM, Franzn S, Gudbjrnsdottir S, et al

These medications have demonstrated remarkable effectiveness in helping people achieve significant weight loss, but they come with some potential side effects that can significantly impact the digestive system and affect quality of life

Antioxidants neutralize oxidants, preventing or limiting cell damage

NextMed Founded: 2020 Total raised: Undisclosed What NextMed does: NextMed began as a COVID-19 testing startup but moved into prescribing GLP-1s for weight loss in July 2022